Mechanism of antibacterial activity of liposomal linolenic acid against helicobacter pylori

PLoS ONE

Volumn 10, Issue 3, 2015, Pages

  Jung, Sung Woo ^a,b   Thamphiwatana, Soracha ^c   Zhang, Liangfang ^c   Obonyo, Marygorret ^a  

^a UNIVERSITY OF CALIFORNIA SAN DIEGO   (United States)

^b Korea University College of Medicine   (South Korea)

^c UNIVERSITY OF CALIFORNIA SAN DIEGO   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADENOSINE TRIPHOSPHATE; LINOLENIC ACID; LIPOSOME; OLEIC ACID; STEARIC ACID; 1 NAPHTHYLAMINE; ANTIINFECTIVE AGENT; N-PHENYL-1-NAPHTHYLAMINE; STEARIC ACID DERIVATIVE;

ANTIBACTERIAL ACTIVITY; ARTICLE; BACTERIAL CELL; BACTERIAL GROWTH; BACTERIAL STRAIN; CELL DEATH; CELL MEMBRANE PERMEABILITY; CONCENTRATION RESPONSE; CONTROLLED STUDY; DRUG FORMULATION; HELICOBACTER PYLORI; NONHUMAN; PROTEIN SYNTHESIS; SCANNING ELECTRON MICROSCOPY; TRANSMISSION ELECTRON MICROSCOPY; ANALOGS AND DERIVATIVES; CELL MEMBRANE; DRUG EFFECTS; HYDRODYNAMICS; METABOLISM; MICROBIAL SENSITIVITY TEST; PARTICLE SIZE; STATIC ELECTRICITY; TIME; ULTRASTRUCTURE;

BACTERIA (MICROORGANISMS); COCCOIDEA; HELICOBACTER PYLORI;

1-NAPHTHYLAMINE; ADENOSINE TRIPHOSPHATE; ALPHA-LINOLENIC ACID; ANTI-BACTERIAL AGENTS; CELL MEMBRANE; HELICOBACTER PYLORI; HYDRODYNAMICS; LIPOSOMES; MICROBIAL SENSITIVITY TESTS; OLEIC ACID; PARTICLE SIZE; STATIC ELECTRICITY; STEARIC ACIDS; TIME FACTORS;

EID: 84925848606     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0116519     Document Type: Article

References (29)

1. Suerbaum S, Michetti P (2002) Helicobacter pylori infection. N Engl J Med 347: 1175-1186. PMID: 12374879
2. Malfertheiner P, Megraud F, O'Morain CA, Atherton J, Axon AT, et al. (2012) Management of Helicobacter pylori infection-the Maastricht IV/ Florence Consensus Report. Gut 61: 646-664. doi: 10.1136/ gutjnl-2012-302084 PMID: 22491499
3. Megraud F (2004) H pylori antibiotic resistance: prevalence, importance, and advances in testing. Gut 53: 1374-1384. PMID: 15306603
4. O'Connor A, Molina-Infante J, Gisbert JP, O'Morain C (2013) Treatment of Helicobacter pylori infection 2013. Helicobacter 18 Suppl 1: 58-65. doi: 10.1111/hel.12075 PMID: 24011247
5. Kabara JJ, Swieczkowski DM, Conley AJ, Truant JP (1972) Fatty acids and derivatives as antimicrobial agents. Antimicrob Agents Chemother 2: 23-28. PMID: 4670656
6. Desbois AP, Smith VJ (2010) Antibacterial free fatty acids: activities, mechanisms of action and biotechnological potential. Appl Microbiol Biotechnol 85: 1629-1642. doi: 10.1007/s00253-009-2355-3 PMID: 19956944
7. Pornpattananangkul D, Fu V, Thamphiwatana S, Zhang L, Chen M, et al. (2013) In Vivo Treatment of Propionibacterium acnes Infection with Liposomal Lauric Acids. Advanced Healthcare Materials 2: 1322-1328. doi: 10.1002/adhm.201300002 PMID: 23495239
8. Thompson L, Cockayne A, Spiller RC (1994) Inhibitory effect of polyunsaturated fatty acids on the growth of Helicobacter pylori: a possible explanation of the effect of diet on peptic ulceration. Gut 35: 1557-1561. PMID: 7828972
9. Sun CQ, O'Connor CJ, Roberton AM (2003) Antibacterial actions of fatty acids and monoglycerides against Helicobacter pylori. FEMS Immunol Med Microbiol 36: 9-17. PMID: 12727360
10. Hazell SL, Graham DY (1990) Unsaturated fatty acids and viability of Helicobacter (Campylobacter) pylori. J Clin Microbiol 28: 1060-1061. PMID: 2112559
11. Khulusi S, Ahmed HA, Patel P, Mendall MA, Northfield TC (1995) The effects of unsaturated fatty acids on Helicobacter pylori in vitro. J Med Microbiol 42: 276-282. PMID: 7707336
12. Obonyo M, Zhang L, Thamphiwatana S, Pornpattananangkul D, Fu V, et al. (2012) Antibacterial activities of liposomal linolenic acids against antibiotic-resistant Helicobacter pylori. Mol Pharm 9: 2677-2685. doi: 10.1021/mp300243w PMID: 22827534
13. Petschow BW, Batema RP, Ford LL (1996) Susceptibility of Helicobacter pylori to bactericidal properties of medium-chain monoglycerides and free fatty acids. Antimicrob Agents Chemother 40: 302-306. PMID: 8834870
14. Correia M, Michel V, Matos AA, Carvalho P, Oliveira MJ, et al. (2012) Docosahexaenoic acid inhibits Helicobacter pylori growth in vitro and mice gastric mucosa colonization. PLoS One 7: e35072. doi: 10. 1371/journal.pone.0035072 PMID: 22529974
15. Duggan AE, Atherton JC, Cockayne A, Balsitis M, Evison S, et al. (1997) Clarification of the link between polyunsaturated fatty acids and Helicobacter pylori-associated duodenal ulcer disease: a dietary intervention study. Br J Nutr 78: 515-522. PMID: 9389880
16. Thamphiwatana S, Gao W, Obonyo M, Zhang L (2014) In vivo treatment of Helicobacter pylori infection with liposomal linolenic acid reduces colonization and ameliorates inflammation. PNAS in press.
17. Thamphiwatana S, Fu V, Zhu J, Lu D, Gao W, et al. (2013) Nanoparticle-Stabilized Liposomes for pHResponsive Gastric Drug Delivery. Langmuir 29: 12228-12233. doi: 10.1021/la402695c PMID: 23987129
18. Lee A, O'Rourke J, De Ungria MC, Robertson B, Daskalopoulos G, et al. (1997) A standardized mouse model of Helicobacter pylori infection: introducing the Sydney strain. Gastroenterology 112: 1386-1397. PMID: 9098027
19. Obonyo M, Sabet M, Cole SP, Ebmeyer J, Uematsu S, et al. (2007) Deficiencies of myeloid differentiation factor 88, Toll-like receptor 2 (TLR2), or TLR4 produce specific defects in macrophage cytokine secretion induced by Helicobacter pylori. Infect Immun 75: 2408-2414. PMID: 17353291
20. Loh B, Grant C, Hancock RE (1984) Use of the fluorescent probe 1-N-phenylnaphthylamine to study the interactions of aminoglycoside antibiotics with the outer membrane of Pseudomonas aeruginosa. Antimicrobial Agents and Chemotherapy 26: 546-551. PMID: 6440475
21. Helander IM, Mattila-Sandholm T (2000) Fluorometric assessment of gram-negative bacterial permeabilization. J Appl Microbiol 88: 213-219. PMID: 10735988
22. Parsons JB, Yao J, Frank MW, Jackson P, Rock CO (2012) Membrane disruption by antimicrobial fatty acids releases low-molecular-weight proteins from Staphylococcus aureus. J Bacteriol 194: 5294-5304. doi: 10.1128/JB.00743-12 PMID: 22843840
23. Huang CM, Chen CH, Pornpattananangkul D, Zhang L, Chan M, et al. (2011) Eradication of drug resistant Staphylococcus aureus by liposomal oleic acids. Biomaterials 32: 214-221. doi: 10.1016/j. biomaterials.2010.08.076 PMID: 20880576
24. Trauble H, Overath P (1973) The structure of Escherichia coli membranes studied by fluorescence measurements of lipid phase transitions. Biochim Biophys Acta 307: 491-512. PMID: 4581497
25. Yang D, Pornpattananangkul D, Nakatsuji T, Chan M, Carson D, et al. (2009) The antimicrobial activity of liposomal lauric acids against Propionibacterium acnes. Biomaterials 30: 6035-6040. doi: 10.1016/j. biomaterials.2009.07.033 PMID: 19665786
26. Brown JC, Jiang X (2013) Activities of muscadine grape skin and polyphenolic constituents against Helicobacter pylori. J Appl Microbiol 114: 982-991. doi: 10.1111/jam.12129 PMID: 23294280
27. Chiu HC, Lin TL, Wang JT (2007) Identification and characterization of an organic solvent tolerance gene in Helicobacter pylori. Helicobacter 12: 74-81. PMID: 17241305
28. Sheu CW, Freese E (1973) Lipopolysaccharide layer protection of gram-negative bacteria against inhibition by long-chain fatty acids. J Bacteriol 115: 869-875. PMID: 4199515
29. Geis G, Leying H, Suerbaum S, OpferkuchW(1990) Unusual fatty acid substitution in lipids and lipopolysaccharides of Helicobacter pylori. J Clin Microbiol 28: 930-932. PMID: 2351736